Abstract
Long-Term Efficacy and Safety of the Oral Pyruvate Kinase Activator Mitapivat in Adults with Non-Transfusion-Dependent Alpha- or Beta-Thalassemia
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have